A pivotal, randomized, cross-over, comparative pharmacokinetic study comparing ZTlido (lidocaine patch 1.8%) with Versatis (lidocaine medicated plaster 5%) in healthy subjects.

Trial Profile

A pivotal, randomized, cross-over, comparative pharmacokinetic study comparing ZTlido (lidocaine patch 1.8%) with Versatis (lidocaine medicated plaster 5%) in healthy subjects.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jan 2017

At a glance

  • Drugs Lidocaine (Primary) ; Lidocaine (Primary)
  • Indications Postherpetic neuralgia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Jan 2017 New trial record
    • 09 Jan 2017 Results published in the Scilex Pharmaceuticals Media Release
    • 09 Jan 2017 According to a Scilex Pharmaceuticals media release, full data is planned to be filed with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom as part of a hybrid Marketing Authorization Application (MAA) in mid-2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top